Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach. [PDF]
Siva J +12 more
europepmc +1 more source
Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non-Invasive Diagnosis of Bladder Cancer. [PDF]
Wang T +13 more
europepmc +1 more source
The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients With Bladder Cancer: A Meta-Analysis. [PDF]
Shi Y, Luo X, Huang Y, Tan C, Liu J.
europepmc +1 more source
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol. [PDF]
Lister-Whelan R +13 more
europepmc +1 more source
The impact of <i>ERBB2</i> alterations in muscle-invasive bladder cancer after neoadjuvant chemotherapy. [PDF]
Burgess EF +7 more
europepmc +1 more source
Correction to "Metabolic Profiling Reveals Insights Into Bladder Cancer Pathogenesis and Recurrence". [PDF]
europepmc +1 more source
Dose-Escalated Radiation Therapy for Muscle-Invasive Bladder Cancer: A Retrospective Analysis. [PDF]
Chan L +8 more
europepmc +1 more source
Related searches:
Bladder cancer is the second most frequent tumour of the urogenital tract. Tobacco smoke has been shown to increase the risk of bladder cancer two- to fivefold as well as the exposure to metabolites of aniline dyes and other aromatic amines. Seventy-five per cent of bladder cancers are superficial at initial presentation, limited to the mucosa ...
Filippo, de Braud +6 more
openaire +4 more sources
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat +8 more
openaire +2 more sources

